AI assistant
Sending…
Avantor, Inc. — Director's Dealing 2021
Feb 27, 2021
30731_dirs_2021-02-26_e4a6386c-cef3-40d8-adae-5b7a2350a2a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Avantor, Inc. (AVTR)
CIK: 0001722482
Period of Report: 2021-02-24
Reporting Person: Brophy Gerard (EVP, Biopharma Production)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-24 | Common Stock | S | 3059 | $27.93 | Disposed | 172384 | Direct |
Footnotes
F1: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
More from Avantor, Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Board/Management Information
2026
Apr 23
Board/Management Information
2026
Apr 1
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Director's Dealing
2026
Feb 25